Article
Therapeutic potential of <scp>RNA</scp> interference: a new molecular approach to antiviral treatment for hepatitis <scp>C</scp>
9 Oct 2012
Abstract excerpt
Hepatitis C virus (HCV) infection remains a major cause of chronic liver disease with an estimated 170 million carriers worldwide. Current treatments have significant side effects and have met with only partial success. Therefore, alternative antiviral drugs that efficiently block virus production are needed. During recent decades, RNA interference (RNAi) technology has not only become a powerful tool for...
